The relationship of APOE polymorphism and cholesterol levels in normoglycemic and diabetic subjects in a biethnic population from the San Luis Valley, Colorado.

[1]  R. Hamman,et al.  Impact of apolipoprotein E polymorphism in determining interindividual variation in total cholesterol and low density lipoprotein cholesterol in Hispanics and non-Hispanic whites. , 1993, Atherosclerosis.

[2]  M. Rewers,et al.  Is the risk of coronary heart disease lower in Hispanics than in non-Hispanic whites? The San Luis Valley Diabetes Study. , 1993, Ethnicity & disease.

[3]  R. Hamman,et al.  Excess incidence of known non-insulin-dependent diabetes mellitus (NIDDM) in Hispanics compared with non-Hispanic whites in the San Luis Valley, Colorado. , 1993, Ethnicity & disease.

[4]  C. Mamotte,et al.  Apolipoprotein ∈4 homozygosity in young men with coronary heart disease , 1992, The Lancet.

[5]  L. Kuller,et al.  The impact of the apolipoprotein E polymorphism on the lipoprotein profile in insulin-dependent diabetes: the Pittsburgh Epidemiology of Diabetes Complications Study IX. , 1992, Metabolism: clinical and experimental.

[6]  J. Hixson.  Apolipoprotein E polymorphisms affect atherosclerosis in young males. Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. , 1991, Arteriosclerosis and thrombosis : a journal of vascular biology.

[7]  E. Boerwinkle,et al.  The apolipoprotein E polymorphism: a comparison of allele frequencies and effects in nine populations. , 1991, American journal of human genetics.

[8]  D. Hewett‐Emmett,et al.  Frequency and Effects of Apolipoprotein E Polymorphism in Mexican-American NIDDM Subjects , 1991, Diabetes.

[9]  D. Hewett‐Emmett,et al.  Effects of the apolipoprotein E polymorphism on levels of lipids, lipoproteins, and apolipoproteins among Mexican-Americans in Starr County, Texas. , 1991, Arteriosclerosis and thrombosis : a journal of vascular biology.

[10]  S. Haffner,et al.  Myocardial infarction in Mexican-Americans and non-Hispanic whites. The San Antonio Heart Study. , 1991, Circulation.

[11]  L. Chan,et al.  Genetic factors influencing lipoprotein structure: implications for atherosclerosis. , 1990, Laboratory investigation; a journal of technical methods and pathology.

[12]  D. T. Vernier,et al.  Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. , 1990, Journal of lipid research.

[13]  M. Nieminen,et al.  Apoprotein E Polymorphism and Coronary Artery Disease: Increased Prevalence of Apolipoprotein E‐4 in Angiographically Verified Coronary Patients , 1989, Arteriosclerosis.

[14]  R. Hamman,et al.  Methods and prevalence of non-insulin-dependent diabetes mellitus in a biethnic Colorado population. The San Luis Valley Diabetes Study. , 1989, American journal of epidemiology.

[15]  H. Ibayashi,et al.  Phenotypes of apolipoprotein E and abnormalities in lipid metabolism in patients with non-insulin-dependent diabetes mellitus. , 1988, Metabolism: clinical and experimental.

[16]  R. Ferrell,et al.  Genetic studies of human apolipoproteins. V. A novel rapid procedure to screen apolipoprotein E polymorphism. , 1988, Journal of lipid research.

[17]  C. Sing,et al.  Apolipoprotein E polymorphism and atherosclerosis. , 1988, Arteriosclerosis.

[18]  J. Breslow.  Apolipoprotein genetic variation and human disease. , 1988, Physiological reviews.

[19]  M. Weintraub,et al.  Dietary fat clearance in normal subjects is regulated by genetic variation in apolipoprotein E. , 1987, The Journal of clinical investigation.

[20]  M. Eto,et al.  Increased Frequency of Apolipoprotein ∈4 Allele in Type II Diabetes With Hypercholesterolemia , 1987, Diabetes.

[21]  C. Ehnholm,et al.  Intestinal cholesterol absorption efficiency in man is related to apoprotein E phenotype. , 1987, The Journal of clinical investigation.

[22]  G. Utermann,et al.  Apolipoprotein E polymorphism in health and disease. , 1987, American heart journal.

[23]  A. Templeton.  The general relationship between average effect and average excess. , 1987, Genetical research.

[24]  K. Watanabe,et al.  Apolipoprotein E Polymorphism and Hyperlipemia in Type II Diabetics , 1986, Diabetes.

[25]  R. Gregg,et al.  Abnormal in vivo metabolism of apolipoprotein E4 in humans. , 1986, The Journal of clinical investigation.

[26]  E. Boerwinkle,et al.  Bias of the contribution of single-locus effects to the variance of a quantitative trait. , 1986, American journal of human genetics.

[27]  G. Assmann,et al.  Association of apolipoprotein E polymorphism, low-density lipoprotein cholesterol, and coronary artery disease. , 1986, Clinical chemistry.

[28]  P. Dawson,et al.  Synthesis of Apolipoprotein E by Peripheral Tissues , 1985 .

[29]  M. Brown,et al.  The Receptor Model for Transport of Cholesterol in Plasma a , 1985, Annals of the New York Academy of Sciences.

[30]  R. Gregg,et al.  Apolipoprotein E metabolism in normolipoproteinemic human subjects. , 1984, Journal of lipid research.

[31]  F. W. Robertson,et al.  Polymorphism at the Apoprotein‐E locus in relation to risk of coronary disease , 1984, Clinical genetics.

[32]  R. Mahley,et al.  Lipoprotein receptors and cholesterol homeostasis. , 1983, Biochimica et biophysica acta.

[33]  E. Janus,et al.  Genetic variation in human apolipoprotein E. , 1982, Journal of lipid research.

[34]  R. Mahley,et al.  Human E apoprotein heterogeneity. Cysteine-arginine interchanges in the amino acid sequence of the apo-E isoforms. , 1981, The Journal of biological chemistry.

[35]  R. Gregg,et al.  Type III hyperlipoproteinemia: defective metabolism of an abnormal apolipoprotein E. , 1981, Science.

[36]  J. Breslow,et al.  Human apolipoprotein E isoprotein subclasses are genetically determined. , 1981, American journal of human genetics.

[37]  G. Utermann,et al.  Polymorphism of apolipoprotein E , 1979, Clinical genetics.

[38]  W. Richmond.  Preparation and properties of a cholesterol oxidase from Nocardia sp. and its application to the enzymatic assay of total cholesterol in serum. , 1973, Clinical chemistry.

[39]  R. Levy,et al.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. , 1972, Clinical chemistry.